Wang X, Song B, Zang M, Ji H, Yang H, Jiang S
J Cell Mol Med. 2021; 25(17):8174-8186.
PMID: 34309216
PMC: 8419185.
DOI: 10.1111/jcmm.16657.
Kim T, Woo S, Han S, Suh C, Ghafoor S, Hricak H
Korean J Radiol. 2020; 21(6):684-694.
PMID: 32410407
PMC: 7231615.
DOI: 10.3348/kjr.2019.0842.
Cybulski A, Catania M, Brancato S, Cogo N, Paola V, Mucelli R
Radiol Med. 2019; 124(10):946-954.
PMID: 31197647
DOI: 10.1007/s11547-019-01047-3.
Caglic I, Povalej Brzan P, Warren A, Bratt O, Shah N, Barrett T
Eur Radiol. 2019; 29(10):5488-5497.
PMID: 30887192
PMC: 6719333.
DOI: 10.1007/s00330-019-06070-6.
Jaderling F, Nyberg T, Oberg M, Carlsson S, Skorpil M, Blomqvist L
Acta Radiol Open. 2018; 7(2):2058460118754607.
PMID: 29456872
PMC: 5810977.
DOI: 10.1177/2058460118754607.
A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient.
Rud E, Diep L, Baco E
World J Urol. 2018; 36(4):629-637.
PMID: 29349572
DOI: 10.1007/s00345-018-2171-4.
Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
Kido A, Tamada T, Sone T, Kanomata N, Miyaji Y, Yamamoto A
Radiol Med. 2016; 122(3):228-238.
PMID: 27943099
DOI: 10.1007/s11547-016-0712-8.
PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.
El-Shater Bosaily A, Parker C, Brown L, Gabe R, Hindley R, Kaplan R
Contemp Clin Trials. 2015; 42:26-40.
PMID: 25749312
PMC: 4460714.
DOI: 10.1016/j.cct.2015.02.008.
Multiparametric magnetic resonance imaging of the prostate: current concepts.
Bittencourt L, Hausmann D, Sabaneeff N, Gasparetto E, Barentsz J
Radiol Bras. 2015; 47(5):292-300.
PMID: 25741104
PMC: 4341390.
DOI: 10.1590/0100-3984.2013.1863.
Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer.
Min B, Kim W, Cho B, Kim Y, Yun S, Lee S
Korean J Urol. 2013; 53(12):830-5.
PMID: 23301126
PMC: 3531635.
DOI: 10.4111/kju.2012.53.12.830.
Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer.
Kim B, Kim T, Kwon T, Yoo E
Yonsei Med J. 2012; 53(3):550-6.
PMID: 22476999
PMC: 3343444.
DOI: 10.3349/ymj.2012.53.3.550.
Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy.
Roethke M, Lichy M, Kniess M, Werner M, Claussen C, Stenzl A
World J Urol. 2012; 31(5):1111-6.
PMID: 22249342
DOI: 10.1007/s00345-012-0826-0.
Clinical application of a 3D ultrasound-guided prostate biopsy system.
Natarajan S, Marks L, Margolis D, Huang J, Macairan M, Lieu P
Urol Oncol. 2011; 29(3):334-42.
PMID: 21555104
PMC: 3432280.
DOI: 10.1016/j.urolonc.2011.02.014.
The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score.
Ko Y, Sung D, Kang S, Kang S, Lee J, Kim J
Asian J Androl. 2011; 13(3):487-93.
PMID: 21383671
PMC: 3739336.
DOI: 10.1038/aja.2010.165.
Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.
Wang L
World J Radiol. 2010; 1(1):3-14.
PMID: 21160716
PMC: 2999304.
DOI: 10.4329/wjr.v1.i1.3.
The role of endorectal magnetic resonance imaging in predicting extraprostatic extension and seminal vesicle invasion in clinically localized prostate cancer.
Park S, Kim J, Kim T, Lim S, Han D, Park B
Korean J Urol. 2010; 51(5):308-12.
PMID: 20495692
PMC: 2873883.
DOI: 10.4111/kju.2010.51.5.308.
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?.
Wang L, Akin O, Mazaheri Y, Ishill N, Kuroiwa K, Zhang J
BJU Int. 2010; 106(9):1303-8.
PMID: 20394616
PMC: 4041605.
DOI: 10.1111/j.1464-410X.2010.09346.x.
MR imaging-guided interventions in the genitourinary tract: an evolving concept.
Fennessy F, Tuncali K, Morrison P, Tempany C
Magn Reson Imaging Clin N Am. 2009; 18(1):11-28.
PMID: 19962090
PMC: 4072848.
DOI: 10.1016/j.mric.2009.09.002.
Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.
Westphalen A, McKenna D, Kurhanewicz J, Coakley F
J Endourol. 2008; 22(4):789-94.
PMID: 18366322
PMC: 2745629.
DOI: 10.1089/end.2007.9822.
MR imaging-guided interventions in the genitourinary tract: an evolving concept.
Fennessy F, Tuncali K, Morrison P, Tempany C
Radiol Clin North Am. 2008; 46(1):149-66, vii.
PMID: 18328885
PMC: 3403748.
DOI: 10.1016/j.rcl.2008.01.004.